IRIS Accounts Production v23.3.0.418 SC084263 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false true false Ordinary £1 shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC0842632022-03-31SC0842632023-03-31SC0842632022-04-012023-03-31SC0842632021-03-31SC0842632021-04-012022-03-31SC0842632022-03-31SC084263ns10:Originalns15:Scotland2022-04-012023-03-31SC084263ns14:PoundSterlingns10:Original2022-04-012023-03-31SC084263ns10:Originalns10:Director12022-04-012023-03-31SC084263ns10:Original2022-04-012023-03-31SC084263ns10:Original2023-03-31SC084263ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-31SC084263ns10:Originalns10:SmallEntities2022-04-012023-03-31SC084263ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-31SC084263ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-31SC084263ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-31SC084263ns10:Originalns10:FullAccounts2022-04-012023-03-31SC084263ns10:Originalns10:OrdinaryShareClass12022-04-012023-03-31SC084263ns10:Originalns10:Director22022-04-012023-03-31SC084263ns10:Originalns10:RegisteredOffice2022-04-012023-03-31SC084263ns10:Original2022-03-31SC084263ns10:Originalns5:CurrentFinancialInstruments2023-03-31SC084263ns10:Originalns5:CurrentFinancialInstruments2022-03-31SC084263ns5:ShareCapitalns10:Original2023-03-31SC084263ns5:ShareCapitalns10:Original2022-03-31SC084263ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-31SC084263ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-31SC084263ns10:Originalns5:FurnitureFittings2022-04-012023-03-31SC084263ns10:Originalns5:ComputerEquipment2022-04-012023-03-31SC084263ns10:Original2021-04-012022-03-31SC084263ns10:Originalns5:FurnitureFittings2022-03-31SC084263ns10:Originalns5:ComputerEquipment2022-03-31SC084263ns10:Original2022-03-31SC084263ns10:Originalns5:FurnitureFittings2023-03-31SC084263ns10:Originalns5:ComputerEquipment2023-03-31SC084263ns10:Originalns5:FurnitureFittings2022-03-31SC084263ns10:Originalns5:ComputerEquipment2022-03-31SC084263ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-31SC084263ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-31SC084263ns10:Originalns5:DeferredTaxation2022-03-31SC084263ns10:Originalns5:DeferredTaxation2022-04-012023-03-31SC084263ns10:Originalns5:DeferredTaxation2023-03-31SC084263ns10:Originalns10:OrdinaryShareClass12023-03-31
REGISTERED NUMBER: SC084263 (Scotland)















Unaudited Financial Statements for the Year Ended 31 March 2023

for

Govanhill Pharmacy Limited

Govanhill Pharmacy Limited (Registered number: SC084263)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Govanhill Pharmacy Limited

Company Information
for the Year Ended 31 March 2023







DIRECTORS: John M Gilbride
I McDowall





REGISTERED OFFICE: Netherplace House
Netherplace Road
Glasgow
G77 6PP





REGISTERED NUMBER: SC084263 (Scotland)





ACCOUNTANTS: Stevenson & Kyles
Chartered Accountants
25 Sandyford Place
Glasgow
G3 7NG

Govanhill Pharmacy Limited (Registered number: SC084263)

Balance Sheet
31 March 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 - 836

CURRENT ASSETS
Stock 75,350 72,100
Debtors 5 538,168 418,460
Cash at bank and in hand 69,907 119,906
683,425 610,466
CREDITORS
Amounts falling due within one year 6 636,345 598,220
NET CURRENT ASSETS 47,080 12,246
TOTAL ASSETS LESS CURRENT
LIABILITIES

47,080

13,082

PROVISIONS FOR LIABILITIES 7 - 163
NET ASSETS 47,080 12,919

CAPITAL AND RESERVES
Called up share capital 8 1,000 1,000
Retained earnings 46,080 11,919
SHAREHOLDERS' FUNDS 47,080 12,919

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Govanhill Pharmacy Limited (Registered number: SC084263)

Balance Sheet - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 7 November 2023 and were signed on its behalf by:





John M Gilbride - Director


Govanhill Pharmacy Limited (Registered number: SC084263)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

Govanhill Pharmacy Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fittings and equipment - 10% on cost
Computer equipment - 25% on cost

Stocks
Stock are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
Basic financial instruments, including debtors and creditors with no stated interest rate and receivable or payable within one year, are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in administrative expenses.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Govanhill Pharmacy Limited (Registered number: SC084263)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Grant income
Where applicable, grants from the government are recognised at their fair value where there is a reasonable assurance that the grant will be received and that the company will comply with all attached conditions. Where the grant income relates to a particular expense item, the grant income is recognised in the profit and loss account over the same period as the expense it is intended to compensate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 (2022 - 9 ) .

4. TANGIBLE FIXED ASSETS
Fittings
and Computer
equipment equipment Totals
£    £    £   
COST
At 1 April 2022
and 31 March 2023 24,446 3,350 27,796
DEPRECIATION
At 1 April 2022 24,446 2,514 26,960
Charge for year - 836 836
At 31 March 2023 24,446 3,350 27,796
NET BOOK VALUE
At 31 March 2023 - - -
At 31 March 2022 - 836 836

Govanhill Pharmacy Limited (Registered number: SC084263)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 235,948 131,887
Other debtors 302,220 286,573
538,168 418,460

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 243,927 245,110
Taxation and social security 50,899 45,937
Other creditors 341,519 307,173
636,345 598,220

7. PROVISIONS FOR LIABILITIES
2023 2022
£    £   
Deferred tax - 163

Deferred
tax
£   
Balance at 1 April 2022 163
Provided during year (163 )
Balance at 31 March 2023 -

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
1,000 Ordinary £1 shares £1 1,000 1,000